RNC Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $475K | Sell |
19,094
-50
| -0.3% | -$1.26K | 0.02% | 138 |
|
|
2025
Q3 | $488K | Sell |
19,144
-3,411
| -15% | -$84.2K | 0.02% | 135 |
|
|
2025
Q2 | $547K | Buy |
22,555
+8,695
| +63% | +$203K | 0.03% | 119 |
|
|
2025
Q1 | $351K | Buy |
13,860
+407
| +3% | +$10.7K | 0.02% | 137 |
|
|
2024
Q4 | $357K | Sell |
13,453
-40,660
| -75% | -$1.1M | 0.02% | 126 |
|
|
2024
Q3 | $1.51M | Hold |
54,113
| – | – | 0.08% | 82 |
|
|
2024
Q2 | $1.51M | Buy |
54,113
+3,194
| +6% | +$87.9K | 0.08% | 82 |
|
|
2024
Q1 | $1.41M | Buy |
50,919
+13,838
| +37% | +$384K | 0.08% | 82 |
|
|
2023
Q4 | $1.07M | Sell |
37,081
-26,801
| -42% | -$810K | 0.06% | 92 |
|
|
2023
Q3 | $2.12M | Sell |
63,882
-29,879
| -32% | -$1.06M | 0.13% | 71 |
|
|
2023
Q2 | $3.44M | Buy |
93,761
+13,359
| +17% | +$520K | 0.19% | 69 |
|
|
2023
Q1 | $3.28M | Sell |
80,402
-1,125
| -1% | -$48.6K | 0.19% | 70 |
|
|
2022
Q4 | $4.18M | Sell |
81,527
-7,741
| -9% | -$371K | 0.23% | 59 |
|
|
2022
Q3 | $3.91M | Sell |
89,268
-2,219
| -2% | -$108K | 0.25% | 66 |
|
|
2022
Q2 | $4.8M | Buy |
91,487
+10,424
| +13% | +$531K | 0.27% | 58 |
|
|
2022
Q1 | $4.2M | Buy |
81,063
+25,987
| +47% | +$1.35M | 0.21% | 75 |
|
|
2021
Q4 | $3.25M | Buy |
55,076
+1,935
| +4% | +$95.9K | 0.16% | 78 |
|
|
2021
Q3 | $2.29M | Buy |
53,141
+134
| +0.3% | +$5.94K | 0.12% | 84 |
|
|
2021
Q2 | $2.08M | Sell |
53,007
-1,843
| -3% | -$71.7K | 0.11% | 88 |
|
|
2021
Q1 | $1.99M | Sell |
54,850
-13,105
| -19% | -$465K | 0.11% | 86 |
|
|
2020
Q4 | $2.5M | Buy |
67,955
+2,112
| +3% | +$77.5K | 0.16% | 79 |
|
|
2020
Q3 | $2.29M | Buy |
65,843
+1,120
| +2% | +$39.3K | 0.16% | 75 |
|
|
2020
Q2 | $2.01M | Buy |
64,723
+4,431
| +7% | +$151K | 0.14% | 73 |
|
|
2020
Q1 | $1.87M | Sell |
60,292
-1,202
| -2% | -$41K | 0.16% | 70 |
|
|
2019
Q4 | $2.29M | Buy |
61,494
+4,688
| +8% | +$167K | 0.14% | 78 |
|
|
2019
Q3 | $1.94M | Sell |
56,806
-10,574
| -16% | -$385K | 0.14% | 74 |
|
|
2019
Q2 | $2.77M | Buy |
67,380
+5,639
| +9% | +$224K | 0.19% | 65 |
|
|
2019
Q1 | $2.49M | Sell |
61,741
-2,778
| -4% | -$111K | 0.17% | 65 |
|
|
2018
Q4 | $2.67M | Sell |
64,519
-5,686
| -8% | -$236K | 0.2% | 60 |
|
|
2018
Q3 | $2.94M | Sell |
70,205
-9,680
| -12% | -$373K | 0.19% | 60 |
|
|
2018
Q2 | $2.75M | Sell |
79,885
-1,021,742
| -93% | -$34.9M | 0.19% | 57 |
|
|
2018
Q1 | $37.1M | Sell |
1,101,627
-46,418
| -4% | -$1.6M | 2.74% | 15 |
|
|
2017
Q4 | $39.5M | Buy |
1,148,045
+7,926
| +0.7% | +$270K | 2.73% | 13 |
|
|
2017
Q3 | $38.6M | Buy |
1,140,119
+770
| +0.1% | +$24.7K | 2.91% | 12 |
|
|
2017
Q2 | $36.3M | Buy |
1,139,349
+40,705
| +4% | +$1.28M | 2.81% | 12 |
|
|
2017
Q1 | $35.7M | Buy |
1,098,644
+46,875
| +4% | +$1.48M | 2.84% | 11 |
|
|
2016
Q4 | $32.4M | Buy |
1,051,769
+37,095
| +4% | +$1.13M | 2.68% | 10 |
|
|
2016
Q3 | $32.6M | Buy |
1,014,674
+25,411
| +3% | +$850K | 2.9% | 10 |
|
|
2016
Q2 | $33M | Buy |
989,263
+5,178
| +0.5% | +$165K | 3.09% | 7 |
|
|
2016
Q1 | $27.7M | Buy |
984,085
+14,681
| +2% | +$419K | 2.73% | 13 |
|
|
2015
Q4 | $29.7M | Sell |
969,404
-175,538
| -15% | -$5.52M | 2.98% | 6 |
|
|
2015
Q3 | $34.1M | Sell |
1,144,942
-18,163
| -2% | -$582K | 3.29% | 7 |
|
|
2015
Q2 | $37M | Sell |
1,163,105
-17,959
| -2% | -$585K | 3.15% | 10 |
|
|
2015
Q1 | $39M | Sell |
1,181,064
-37,279
| -3% | -$1.19M | 3.27% | 8 |
|
|
2014
Q4 | $36M | Sell |
1,218,343
-19,775
| -2% | -$567K | 2.95% | 10 |
|
|
2014
Q3 | $34.7M | Buy |
1,238,118
+49,137
| +4% | +$1.38M | 2.79% | 13 |
|
|
2014
Q2 | $33.5M | Buy |
1,188,981
+14,391
| +1% | +$410K | 2.7% | 15 |
|
|
2014
Q1 | $35.8M | Buy |
1,174,590
+9,100
| +0.8% | +$271K | 3.11% | 11 |
|
|
2013
Q4 | $33.9M | Buy |
1,165,490
+22,582
| +2% | +$657K | 3.02% | 12 |
|
|
2013
Q3 | $31.1M | Buy |
1,142,908
+40,661
| +4% | +$1.11M | 3.14% | 10 |
|
|
2013
Q2 | $29.3M | Buy |
+1,102,247
| New | +$30.5M | 3.1% | 8 |
|
Other funds holding PFE
RNC Capital Management's PFE Position: Q4 2025 in Review
RNC Capital Management reduced its Pfizer (PFE) stake by 0.26% in Q4 2025, selling an estimated $1.26K and leaving 19,094 shares worth $475K. The position accounts for 0.02% of the portfolio, ranked #138.
RNC Capital Management first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $39.5M in Q4 2017. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- RNC Capital Management held 19,094 shares of Pfizer worth $475K as of Q4 2025.
- RNC Capital Management sold 50 Pfizer shares in Q4 2025, an estimated $1.26K.
- Pfizer made up 0.02% of RNC Capital Management's portfolio in Q4 2025, its #138 holding.
- RNC Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
- RNC Capital Management's Pfizer position peaked at $39.5M in Q4 2017.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on RNC Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.